Catalan Life Sciences Database

CORK, Ireland, Aug. 22, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results from the Phase 3 ATLAS-2M study of the investigational, long-acting two-drug injectable regimen of its rilpivirine and ViiV Healthcare's... Read more ››

By: PR Newswire Association LLC. - 22 Aug 2019

Steward Health Care Signs Long-Term Agreement with B. Braun for IV Solutions and Infusion Pumps

By: Nasdaq / GlobenewsWire - 21 Aug 2019

PharmaMar will submit NDA for lurbinectedin under accelerated approval in SCLC in the USA

MADRID, Aug. 19, 2019 /PRNewswire/ -- PharmaMar (MSE: PHM) today announced that the FDA (Food and Drug Administration) agreed with PharmaMar's proposal to file for accelerated approval its New Drug Application (NDA) for lurbinectedin monotherapy for the treatment of second-line SCLC.

By: PR Newswire Association LLC. - 19 Aug 2019

Related companies: PHARMA MAR, S.A.

« 1 2 3 4 5 6 7 »

Looking for companies outside of Catalonia?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

October 2019
- Rennes: NutrEvent
- San Francisco: BIO Investor Forum
- Melbourne: Biotech-Pharma Product and Company Valuation - introduction

See Events »

Add an Event »

Latest company news

Novo Nordisk A/S – Share repurchase programme
21 Oct 2019 (Nasdaq / GlobenewsWire)

Sanofi: information concerning the total number of voting rights and shares, September 2019
21 Oct 2019 (Nasdaq / GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
14 Oct 2019 (Nasdaq / GlobenewsWire)

News in the Life Sciences Industry

Novo Nordisk A/S – Share repurchase programme

ORYZON’s Iadademstat Shows Efficacy Signs in Relapsed SCLC

B. Braun Successfully Integrates with West-Com at Fairchild Medical Center

ORYZON to Present at Upcoming International Conferences

Novo Nordisk A/S – Share repurchase programme

Germany becomes first launch market for ALK’s tree SLIT-tablet

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

B. Braun Interventional Systems Expands its Congenital and Structural Heart Portfolio With the EmeryGlide™ MR Conditional Guidewire From Nano4Imaging

Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9

Novo Nordisk A/S – Share repurchase programme

Janssen Reports Positive Top-line Phase 3 Study Results of Investigational, Long-acting Injectable HIV Treatment Regimen Administered Every Two Months

Steward Health Care Signs Long-Term Agreement with B. Braun for IV Solutions and Infusion Pumps

PharmaMar will submit NDA for lurbinectedin under accelerated approval in SCLC in the USA

Novo Nordisk A/S – Share repurchase programme

Sanofi: information concerning the total number of voting rights and shares, July 2019

Novo Nordisk A/S: Securities lawsuit filed in Denmark against Novo Nordisk

B. Braun Successfully Integrates with Epic at Prime Healthcare – Huntington Beach Hospital

Six-month interim report (Q2) 2019

Trading in Novo Nordisk shares by board members, executives and associated persons on 9 August 2019

ALK upgrades its full-year financial outlook due to strong growth

Looking for companies outside of Catalonia?

Partners

Upcoming Life Sciences Events

Latest company news